90 related articles for article (PubMed ID: 3355096)
1. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis.
Gelman BB; Rifai N; Christenson RH; Silverman LM
Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096
[TBL] [Abstract][Full Text] [Related]
2. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination.
Rifai N; Christenson RH; Gelman BB; Silverman LM
Clin Chem; 1987 Jul; 33(7):1155-7. PubMed ID: 3594843
[TBL] [Abstract][Full Text] [Related]
3. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
[TBL] [Abstract][Full Text] [Related]
4. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.
Boyles JK; Pitas RE; Wilson E; Mahley RW; Taylor JM
J Clin Invest; 1985 Oct; 76(4):1501-13. PubMed ID: 3932467
[TBL] [Abstract][Full Text] [Related]
6. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.
Link H; Tibbling G
Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461
[TBL] [Abstract][Full Text] [Related]
7. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
8. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
Kaysen GA; Jones H; Joles JA; van Tol A
Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
[TBL] [Abstract][Full Text] [Related]
9. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
10. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
11. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
Bartosik-Psujek H; Archelos JJ
J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
[TBL] [Abstract][Full Text] [Related]
12. IgG production within the central nervous system: a critical review of proposed formulae.
Lefvert AK; Link H
Ann Neurol; 1985 Jan; 17(1):13-20. PubMed ID: 3985580
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation.
Gaillard O; Gervais A; Meillet D; Plassart E; Fontaine B; Lyon-Caen O; Delattre J; Schuller E
J Neurol Sci; 1998 Jun; 158(2):180-6. PubMed ID: 9702689
[TBL] [Abstract][Full Text] [Related]
14. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
[TBL] [Abstract][Full Text] [Related]
16. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
Cognazzo A; Gerbino Promis PC; Grasso E
Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
[TBL] [Abstract][Full Text] [Related]
17. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of lipids and apolipoprotein E in angiographically defined coronary artery disease patients.
Leowattana W; Pokum S; Mahanonda N; Jiumbunjong N
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S684-9. PubMed ID: 12002910
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide as an activity marker in multiple sclerosis.
Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
[TBL] [Abstract][Full Text] [Related]
20. Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis.
D'Aguanno S; Barassi A; Lupisella S; d'eril GM; Del Boccio P; Pieragostino D; Pallotti F; Carelli V; Valentino ML; Liguori R; Avoni P; Bernardini S; Gambi D; Urbani A; Federici G
J Neuroimmunol; 2008 Jan; 193(1-2):156-60. PubMed ID: 18061280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
